UCB’s Vimpat gets NHS green light in Wales
The All Wales Medicines Strategy Group has approved NHS funding for the use of UCB’s Vimpat in children with epilepsy.
Read More
Tag: Wales
Pfizer’s Somavert to be funded by NHS Wales
Pfizer’s Somavert will be funded by NHS Wales as a treatment for eligible, adult patients with acromegaly in the third-line setting.
Read More
Wales sees 400% leap in patients waiting more than a year for surgery
The number of patients waiting for more than a year for surgical treatment on the NHS in Wales has rocketed more than 400 percent in four years.
Read More
Welsh gov’t brings in new bowel, cervical cancer tests
The Welsh government has announced plans for more accurate and user-friendly tests for cervical cancer and bowel cancer screening in a bid to save more lives.
Read More
Welsh gov launches £80m new treatment fund
A five-year, £80 million new treatment fund has now been launched in Wales in the hope of accelerating patient access to novel therapies.
Read More
No funding cut for pharmacy in Wales, says gov
The Welsh Assembly has announced that it will maintain funding for community pharmacy over the next two years, just days after the UK government revealed severe budget cuts for the sector in England.
Read More
Wales confirms £80m treatment fund
A new £80 million fund designed to help accelerate access to treatments for patients with life-threatening illnesses in Wales has now been confirmed by the Welsh government.
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
